| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0049 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |